Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (6): 741-749.doi: 10.12092/j.issn.1009-2501.2025.06.003
Previous Articles Next Articles
DU Xueyang1, NIU Fanqi1, DONG Xiaoping1, YANG Pengfei1, ZHOU Wenli2, WANG Sinong1
Received:2024-09-29
Revised:2024-11-05
Online:2025-06-26
Published:2025-06-09
CLC Number:
DU Xueyang, NIU Fanqi, DONG Xiaoping, YANG Pengfei, ZHOU Wenli, WANG Sinong. Mechanism of Sanhuang Gel regulating TLRs/NLRP3 signaling pathway to improve acne model in rats[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 741-749.
| [1] | LIU Xun, ZHOU Tingting, ZHU Zibing, TAN Jin, LI Qun. Arecoline promotes oral submucous fibrosis by upregulating PI3K/Akt/mTOR signaling pathway in vivo and in vitro [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 865-875. |
| [2] | WANG Yundong, LI Xuening, LI Moxuan, CAO Wenjing, RONG Hao, YANG Chen, ZHU Xuerui, XU Xinyu, WANG Ye, ZHANG Ya, JIN Huanhuan, HONG Zongyuan, ZHANG Junxiu. Mechanisms of sesamin on the prevention and treatment of fatty liver disease in hypertensive rats with dyslipidemia based on mRNA-seq [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 876-888. |
| [3] | HUANG Yunchao, WANG Yiqiong, ZHANG Ting, ZHANG Jun, LI Lan, ZHANG Ling. Study on the effects of crocetin in improving lower limb ischemia in diabetes mellitus through Anti-inflammatory actions and promotion of angiogenesis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 899-906. |
| [4] |
LI Qian, WANG Zhenxiang, LIANG Yanting, MA Weiwei, ZHANG Zhen, WANG Xia, AN Qiong.
Effect and mechanism of Tamarix chinensis Lour. on streptozotocin-induced diabetic rats based on network pharmacology, molecular docking and experimental validation
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 907-920.
|
| [5] | YANG Huanran, WU Shengnan, GAO Qin. Dexmedetomidine alleviates ferroptosis in rat cerebral ischemia/reperfusion injury by inhibiting the Nrf2 pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 921-928. |
| [6] | ZHU Xianjun, ZHANG Danni, LUO Xijun, LIANG Junjie, LI Tao, TANG Xingkui, HE Jialin, LI Wei. Reversal of trastuzumab resistance in gastric cancer cells by targeting GPRC5A with miR-195-5p [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 929-934. |
| [7] | YANG Gengqiang, LI Yangyang, LI Qiyang, ZHANG Shangzu, YANG Yue, ZHOU Ting, ZHANG Liying. PX-478 enhances the effect of lung cancer radiotherapy by regulating HIF-1α-mediated glycolysis [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(7): 935-941. |
| [8] |
SU Hong, CHENG Qian, WANG Yaxuan, DAI Chongyang, ZHAO Fubang , PU Xiaoyan.
Dynamic changes of neutrophil extracellular traps (NETs) release and microcirculatory disorders associated with high altitude pulmonary edema after high altitude hypoxia exposure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 732-740.
|
| [9] | LIN Jingyi, HAN Rangyue, XU Linghui, TAN Ruizhi, SU Hongwei, WANG Li. Huangqi sanqi mixture inhibits lncRNA Gm51500/Adam12 axis to improve renal fibrosis in CKD [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 750-762. |
| [10] | YANG Weidong, WANG Ruiqi, WANG Haihua, YE Tianxiang, CHENG Shenghui, LI Huifang, HAO Xuliang. Flavonoid extract from Dracocephalum rupestre hance in improving gouty arthritis: study based on network pharmacology, molecular docking and animal experiment [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 763-773. |
| [11] | ZHANG Yidan, SUN Xinghua, QU Yang, HU Xiaoyang, ZHANG Miao. Research progress on the regulation of PI3K/Akt signaling pathway by active ingredients of traditional Chinese medicine in the treatment of cerebral ischemia-reperfusion injury [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(6): 820-827. |
| [12] | WANG Guowei, ZHUO Tao, ZHENG Quanwei, LI Mengying, LI Jiehui, LIU Jianhang. Cuttlebone extract on wound healing and VEGF/PI3K/Akt pathway in rats with refractory ulcers [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 577-585. |
| [13] | LI Mingqi, WANG Yinghe, ZHAO Xiaolu, BAO Xiaomei, YUE Xin, REN Guiqiang, MA Yuehong. Mechanism of total flavonoids of Carthamus tinctorius L.against hepatic fibrosis based on LC-MS/MS combined with network pharmacology and pharmacology experiments [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 586-598. |
| [14] | DU Lijuan, LIN Jianhua, YE Jinghuan, SONG Lu, PENG Yanfen, LIU Yuping. Effect and mechanism of Yiqi tongfu xiere prescription on lipopolysaccharide-induced acute lung injury in mice [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 599-607. |
| [15] | YANG Dongli, LI Jing, DUAN Lifang, ZHANG Wenjiang, LI Na, ZHANG Hong. Advances in the anti-fibrosis effect of oxidative stress-related regulatory protein Cygb [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(5): 683-689. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||